We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » McNeil Manufacturing Distress to Drag Into 2013, J&J Says
McNeil Manufacturing Distress to Drag Into 2013, J&J Says
May 7, 2012
Efforts to alleviate manufacturing distress at three McNeil Consumer Healthcare plants will take longer and cost more than expected, forcing the Johnson & Johnson (J&J) subsidiary to trickle out OTC drug products through 2013 and its parent company to sweat over sales in 2012, J&J says.